Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases

NCT01508000 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

44

Enrollment

NETWORK

Sponsor class

Stopped Low or poor accrual

Conditions

Colorectal Cancer Metastatic
Liver Metastases
KRAS Wild Type Colorectal Cancer

Interventions

DRUG: FOLFOX6
BIOLOGICAL: Bevacizumab
BIOLOGICAL: Panitumumab
PROCEDURE: Surgery

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]
[object Object]